Yükleniyor... / Loading...
This study compared a streamlined genetic education approach with traditional genetic education in patients with ovarian cancer. It enrolled patients diagnosed with high-grade epithelial ovarian, fallopian tube, or peritoneal cancer. This is a study without an assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Either a) pathologically confirmed diagnosis of high-grade epithelial ovarian, fallopian or peritoneal cancer via biopsy or surgical pathology or b) cytologic diagnosis consistent with high-grade epithelial ovarian cancer. * Presenting to Duke gynecologic oncology clinic or collaborating institution for first outpatient visit following pathologic or cytologic diagnosis. If logistic constraints prevent the patient from being enrolled at her initial visit, she will be eligible for enrollment up to initiation of her fifth cycle of chemotherapy. Exclusion Criteria: * Known family or personal history of an inherited cancer susceptibility mutation * Previously received genetic counseling or testing for an inherited cancer susceptibility mutation * Insurance provided by an insurance company that requires face-to-face genetic consultation prior to testing * Unable to read or speak English as study design includes video assisted educational materials in English * Blind or deaf as study design includes video assisted educational materials in English